Skip to Content

CP 419 (Aspirin, Caffeine, and Dihydrocodeine Bitartrate 356.4 mg / 30 mg / 16 mg)

Pill with imprint CP 419 is Blue & Gray, Capsule-shape and has been identified as Aspirin, Caffeine, and Dihydrocodeine Bitartrate 356.4 mg / 30 mg / 16 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Aspirin/caffeine/dihydrocodeine is used in the treatment of pain and belongs to the drug class narcotic analgesic combinations. FDA has not classified the drug for risk during pregnancy. Aspirin/caffeine/dihydrocodeine 356.4 mg / 30 mg / 16 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for CP 419

Aspirin, Caffeine, and Dihydrocodeine Bitartrate

Imprint
CP 419
Strength
356.4 mg / 30 mg / 16 mg
Color
Blue & Gray
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
N - Not classified
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
57664-0419

Get help with Imprint Code FAQs.

Related Images for "CP 419"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.